Biogen shares plunged 23.7 percent to $57.91. Shares of Dow Chemical ( DOW.N ) shot higher after the company said it is forming a joint plastics venture with a unit of Kuwait Petroleum. Dow shares were up 6.3 percent at $44.39. Data on the consumer was a bright spot. A government report showing retail sales jumped in November more than economists had forecast suggested holiday shoppers were coping with high energy costs and the fallout from the housing slump.

-----

NEW YORK  (Reuters) - The Dow Jones industrial average rose on Thursday after economic bellwether Honeywell International raised its profit forecast, offsetting doubts about whether a global plan to thaw credit markets could work.But the broader market closed little changed, as Goldman Sachs Group ( GS.N ), Citigroup ( C.N ) and other banks fell on growing pessimism about the scope of a plan announced on Wednesday by global central banks to make it easier for stressed banks to borrow.

-----

The Standard & Poor's 500 Index  .SPX  was up 1.82 points, or 0.12 percent, at 1,488.42. The Nasdaq Composite Index  .IXIC  was down 2.65 points, or 0.10 percent, at 2,668.49. In a sign of skepticism about central bank efforts to combat the credit squeeze, interbank lending rates showed only a slight decline on Thursday.

-----

Merrill Lynch MER.N was off 1.7 percent at $57.83 and Bear Stearns BSC.N was down 2.4 percent to $98.39. Goldman Sachs fell 1.9 percent to $208.48 and Citigroup slid 1.5 percent to $31.01. Shares of Biogen Idec ( BIIB.O ) were the top drag on the Nasdaq after the drug maker ended its own auction on Wednesday to sell itself after failing to get any bidders.

-----

"You've still got a hangover from the Fed," said Phil Orlando, chief equity market strategist at Federated Investors in New York. "Also today, you had hot inflation data, which got the market worried that that could stop the Fed from easing again," Orlando said. "But I think this is a knee-jerk reaction." The Dow  .DJI  was up 44.06 points, or 0.33 percent, at 13,517.96.
